Hudson Bay Capital Management’s AEON Biopharma Inc AEON.WS Stock Holding History

Hudson Bay Capital Management’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-100,000	Closed	-$145K	–	1011
2024 Q1	$145K	Hold	100,000	–	–	﹤0.01%	602
2023 Q4	$9.99K	Hold	100,000	–	–	﹤0.01%	620
2023 Q3	$15K	Hold	100,000	–	–	﹤0.01%	688
2023 Q2	$9K	Hold	100,000	–	–	﹤0.01%	763
2023 Q1	$6K	Hold	100,000	–	–	﹤0.01%	805
2022 Q4	$4.56K	Hold	100,000	–	–	﹤0.01%	912
2022 Q3	$7K	Hold	100,000	–	–	﹤0.01%	1143
2022 Q2	$15K	Hold	100,000	–	–	﹤0.01%	1205
2022 Q1	$30K	Hold	100,000	–	–	﹤0.01%	1073
2021 Q4	$51K	Hold	100,000	–	–	﹤0.01%	1004
2021 Q3	$55K	Hold	100,000	–	–	﹤0.01%	927
2021 Q2	$101K	Buy	+100,000	New	+$75.9K	﹤0.01%	876

Hudson Bay Capital Management's AEON.WS Position: Q2 2024 in Review

Hudson Bay Capital Management sold out of AEON Biopharma Inc (AEON.WS) in Q2 2024, closing a stake of 100,000 shares — an estimated $145K sold.

Hudson Bay Capital Management first reported a position in AEON.WS in Q2 2021 and held it in 12 quarters. The position peaked at $145K in Q1 2024. 0 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2024.

Hudson Bay Capital Management reported no remaining AEON Biopharma Inc position as of Q2 2024 after selling out during the quarter.
Hudson Bay Capital Management sold 100,000 AEON Biopharma Inc shares in Q2 2024, an estimated $145K.
Hudson Bay Capital Management first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 12 quarters.
Hudson Bay Capital Management's AEON Biopharma Inc position peaked at $145K in Q1 2024.
0 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2024.

Based on Hudson Bay Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.